| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 10/12/2006 | CA2602200A1 Control of n-(phosphonomethyl) iminodiacetic acid conversion in manufacture of glyphosate |
| 10/11/2006 | EP1710247A1 Transition metal compound and catalyst for olefin polymerization |
| 10/11/2006 | EP1709968A1 P2x receptor inhibitor |
| 10/11/2006 | EP1709186A1 Charcoal stabilization of phenyl phosphates |
| 10/11/2006 | EP1709055A1 Amino derivatives of dibenz[c,e][1,2]-oxaphosphorine-6-oxides method for production and use thereof |
| 10/11/2006 | EP1709054A1 Metallocene-based chiral phosphine or arsine ligands |
| 10/11/2006 | EP1709051A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 10/11/2006 | EP1709044A2 Oxazolidinone-quinolone hybrid antibiotics |
| 10/11/2006 | EP1708803A2 Use of structured water-soluble polymers obtained by controlled radical polymerization as a dispersant and agent for assisting in the grinding of mineral materials |
| 10/11/2006 | EP1478629B1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
| 10/11/2006 | EP1311344B1 Bicyclic phosphine comprising hydroformylation catalyst and use thereof in production of oxygenated products |
| 10/11/2006 | CN1846456A Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 10/11/2006 | CN1845904A Ophthalmic compositions for treating ocular hypertension |
| 10/11/2006 | CN1844127A Caffeoyl guinic acid-1-phosphate and its preparation and use |
| 10/11/2006 | CN1279649C Non-aqueous electrolyte cell, and phosphazene derivative and method for preparation thereof |
| 10/11/2006 | CN1279048C Deeply reduced oxidation catalyst and its use for catalyzing liquid phase oxidation reactions |
| 10/11/2006 | CN1279047C Mixed bed ion exchange resin method for purifying lecithin and cephalin |
| 10/11/2006 | CN1279046C Fluoroalkyl phosphate for electrochemical cells |
| 10/11/2006 | CN1279033C Improved method for water soluble azole compounds |
| 10/10/2006 | US7119221 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders |
| 10/10/2006 | US7119220 Process for preparing dimethyl propanephosphonate |
| 10/10/2006 | US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer |
| 10/10/2006 | US7118688 tocopherols, beta-carotene, egg yolk or soybean phospholipids, and sucrose or sorbitol are incorporated by homogenization; in the presence of caprine caseinophosphopeptide, eggplant (LBJ 10), and citric acid, certain embodiments of the present invention show enhanced antioxidant activity |
| 10/10/2006 | CA2313676C Polymeric surface coatings |
| 10/10/2006 | CA2276284C Radioiodinated phospholipid ether analogs and methods of using the same |
| 10/10/2006 | CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 10/10/2006 | CA2207672C Process for the carbonylation of ethylene and catalyst system for use therein |
| 10/10/2006 | CA2138882C The preparation of 9-(z)-retinoic acid |
| 10/05/2006 | WO2006105204A2 Compositions and their uses directed to thymus and activation-regulated chemokine (tarc) |
| 10/05/2006 | WO2006104867A1 Hindered amine light stabilizers comprising neoalkanediol phosphites |
| 10/05/2006 | WO2006104120A1 Method for producing l-2-amino-4-(hydroxymethylphosphinyl)- butanoic acid |
| 10/05/2006 | WO2006104030A1 Thiazole compound |
| 10/05/2006 | WO2006103908A1 Organic ligands for semiconductor nanocrystals |
| 10/05/2006 | WO2006103756A1 Process for production of optically active quinuclidinol |
| 10/05/2006 | WO2006103568A2 NEW CLASS OF Ϝδ T CELLS ACTIVATORS AND USE THEREOF |
| 10/05/2006 | WO2006059052A3 Inositol-phosphate derivatives and method of detecting inositol-1-phosphate |
| 10/05/2006 | WO2006020276A3 Antiviral compounds |
| 10/05/2006 | US20060224002 Chiral di- and triphosphites |
| 10/05/2006 | US20060223995 Superhigh purity ionic liquid |
| 10/05/2006 | US20060223888 Valproic acid analogues and pharmaceutical composition thereof |
| 10/05/2006 | US20060223777 Highly functional short hairpin RNA |
| 10/05/2006 | US20060223770 IRNA agents targeting VEGF |
| 10/05/2006 | US20060222584 Salts comprising cyanoborate anions |
| 10/05/2006 | US20060220004 with Tris(2-bromo-6-pyridyl)phosphine oxide ligands; organic light-emitting diodes, integrated circuits, organic field-effect transistors, thin-film transistors, organic solar cells, and/or laser diodes |
| 10/05/2006 | DE19523335B4 6-Vinyl-2,8,13-tetradecatrien-1-ol und Verfahren zur Herstellung von ungesättigten Alkoholen 6-vinyl-2,8,13-tetradecatriene-1-ol and Process for the preparation of unsaturated alcohols |
| 10/05/2006 | CA2602257A1 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors |
| 10/05/2006 | CA2602223A1 New class of yo t cells activators and use thereof |
| 10/04/2006 | EP1706415A1 Lipid- derivatized bisphosphonic acid |
| 10/04/2006 | EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 10/04/2006 | EP1395357B1 Pumpable liquid surfactant compositions comprising alkanolamine salts of alkyl phosphate esters |
| 10/04/2006 | EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 10/04/2006 | CN1842533A Phospinite-imidazolines and metal complexes thereof |
| 10/04/2006 | CN1842512A Bipolar trans carotenoid salts and their uses |
| 10/04/2006 | CN1842496A Tagged scale inhibiting polymers, compositions comprising the same, and method for preventing or controlling scale formation |
| 10/04/2006 | CN1277835C Process for treating glyphosate mother liquid |
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/03/2006 | US7115765 Providing solvent, adding reactant such as 6H-dibenzo[c,e] [1,2]oxaphosphorin 6-oxide, adding an ortho ester and adding alcohol |
| 10/03/2006 | US7115761 Process for the production of monohalide or dihalide metallocene compounds |
| 10/03/2006 | US7115758 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 10/03/2006 | US7115738 Hydroxyproline/phosphono oligonucleotide analogues, methods of synthesis and methods of use |
| 10/03/2006 | US7115720 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 10/03/2006 | US7115661 Methods and compositions for mitigating pain |
| 10/03/2006 | US7115659 Method of treating a condition by administering a prostaglandin derivative |
| 10/03/2006 | US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties |
| 10/03/2006 | US7115592 antiviral agents for treating HIV-1, HIV-2 or hepatitis B viral infections |
| 10/03/2006 | US7115591 Pyridazinone compounds as cyclooxygenase [COX] 2 inhibitorsfor gastrointestinal disorders |
| 10/03/2006 | US7115590 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents |
| 10/03/2006 | US7115589 Phosphorus-containing moietys; kinase inhibitors; improve balance of bone growth relative to bone resorption; inhibit PTH-induced bone resorption; cytotoxic or growth inhibitory effect on cancer cell lines |
| 10/03/2006 | US7115401 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
| 10/03/2006 | CA2319801C Improved separation processes |
| 10/03/2006 | CA2151507C Pharmaceutical composition containing bicyclic type compounds |
| 09/28/2006 | WO2006102576A1 Water-dispersible carotenoids, including analogs and derivatives |
| 09/28/2006 | WO2006100169A2 Unsymmetrically substituted phospholane catalysts |
| 09/28/2006 | WO2006100165A1 Electron-deficient bisphospholane ligands and catalysts |
| 09/28/2006 | WO2005072252A3 Isotopically-enriched boranes and methods of preparing them |
| 09/28/2006 | WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds |
| 09/28/2006 | WO2004069146A3 L-dopa amide derivatives and uses thereof |
| 09/28/2006 | US20060217568 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups |
| 09/28/2006 | US20060217475 Coupling agents for mineral-filled elastomer compositions |
| 09/28/2006 | US20060217474 Coupling agents for mineral-filled elastomer compositions |
| 09/28/2006 | US20060217345 Beta-L-nucleosides and use thereof as pharmaceutical agents for the treatment of viral diseases |
| 09/28/2006 | US20060217339 Breast cancer, prostate cancer, brain cancer, head and neck cancer, myeloma, melanoma, leukemia and lymphoma; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 09/28/2006 | US20060217337 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217336 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 09/28/2006 | US20060217335 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217334 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060216747 first nucleotide sequence complementary to a target RNA sequence or a portion thereof, and a second sequence chemically modified so that it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; pharmaceutical use such as viricide |
| 09/28/2006 | US20060216708 Method for lowering both sequence variations and increase of base lines effects in diagnostic hybridisation assay, assay for performing such a method and probe for use in the assay |
| 09/28/2006 | US20060216381 Aqueous lecithin dispersions |
| 09/28/2006 | DE102005014395A1 New monocylcopentadienyl complex are useful in a catalyst system for (co)polymerization of olefins |
| 09/28/2006 | DE102005014055A1 Unsymmetrisch substituierte Phospholankatalysatoren Asymmetrically substituted Phospholankatalysatoren |
| 09/28/2006 | DE102005014054A1 Elektronenarme Bisphospholanliganden und -katalysatoren Electron-deficient Bisphospholanliganden and catalysts |
| 09/28/2006 | DE102005012115A1 Alkylating triphenylphosphate comprises, reacting triphenylphosphate with olefin in the presence of solid acid catalyst e.g. zeolite, heteropoly acid and metalhalogenide-Lewis acid |
| 09/28/2006 | CA2611137A1 Water-dispersible carotenoids, including analogs and derivatives |
| 09/27/2006 | EP1705199A2 Semiconductor encapsulating epoxy resin composition and semiconductor device |
| 09/27/2006 | EP1704243A2 Oligonucleotide compound and method for treating nidovirus infections |
| 09/27/2006 | EP1704155A1 Sphingomyelin, intermediates thereof and methods for preparation of same |
| 09/27/2006 | EP1703912A1 Compounds for the inhibition of undesired cell proliferation and use thereof |
| 09/27/2006 | EP1648242A4 Emulsions |
| 09/27/2006 | EP1648240A4 Aqueous lecithin dispersions |